| PRD_002334 | Name: | Linear tetrapeptide related to pseudoxylallemycin A | Formula: | C32 H46 N4 O5 | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
| PRD_002306 | Name: | (2S,5R,8S,11S,14R,17S,20S,22R,23S)-5-[(2E)-but-2-en-1-yl]-23-hydroxy-8-({1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-1H-indol-3-yl}methyl)-14-[(4-hydroxy-3-nitrophenyl)methyl]-10,17,19,22-tetramethyl-2,11-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazabicyclo[18.3.1]tetracosane-3,6,9,12,15,18,24-heptone | Formula: | C54 H77 N9 O12 | Definition date: | 2019-06-04 | Last modified: | 2019-06-04 |
|
| PRD_002311 | Name: | ACE-MVA-MP8-NZC-LEU-MP8-LEU-MVA-PRO-MLU-GLY | Formula: | C57 H96 N10 O12 | Definition date: | 2019-05-29 | Last modified: | 2019-05-29 |
|
| PRD_002316 | Name: | Apollo peptide | Formula: | C46 H68 N8 O7 | Definition date: | 2019-02-13 | Last modified: | 2019-02-13 |
|
| PRD_002317 | Name: | N-Me-p-iodo-D-Phe1,N-Me-D-Gln4,Lys10-teixobactin analogue | Formula: | C59 H99 I N13 O15 | Definition date: | 2018-10-17 | Last modified: | 2018-10-17 |
|
| PRD_002324 | Name: | [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN | Formula: | C62 H111 N11 O13 | Definition date: | 2018-09-12 | Last modified: | 2018-09-12 |
|
| PRD_002302 | Name: | benzyl [(6S,7S,10S,13S,18Z)-18-amino-10-cyclohexyl-6-hydroxy-18-imino-7-(2-methylpropyl)-4,9,12-trioxo-1-phenyl-16-oxa-3,8,11,17-tetraazaoctadecan-13-yl]carbamate | Formula: | C37 H55 N7 O7 | Definition date: | 2018-06-13 | Last modified: | 2018-06-13 |
|
| PRD_001186 | Name: | Myosin-A, stapled peptide | Formula: | C97 H175 N31 O23 S | Description: | SYNTHESISED PEPTIDE MIMIC OF PLASMODIUM FALCIPARUM MYOSIN A TAIL | Definition date: | 2013-11-06 | Last modified: | 2017-12-15 |
|
| PRD_002275 | Formula: | C35 H59 N14 O13 | Definition date: | 2017-06-14 | Last modified: | 2017-12-15 |
|
| PRD_002277 | Name: | N-{(2S,4R)-2-[(1R)-3-amino-1-({N-[(2R)-2-{(1R)-1-[(N-{(2S)-2-[(1S)-3-amino-1-({N-[(3S,6R)-3-(3-amino-3-oxopropyl)-6-(hydroxymethyl)-5-oxo-3,4,5,6-tetrahydropyrazin-2-yl]-L-seryl-L-prolylglycyl}amino)-3-oxopropyl]-2,3-dihydro-1,3-thiazole-4-carbonyl}-L-alanyl)amino]-2-hydroxyethyl}-2,3-dihydro-1,3-thiazole-4-carbonyl]-L-seryl}amino)-3-oxopropyl]-1,3-oxazolidine-4-carbonyl}-L-alanyl-L-seryl-N-{(1S)-3-amino-1-[(2S)-4-{[(2S,3S)-3-hydroxy-1-oxobutan-2-yl]carbamoyl}-2,3-dihydro-1,3-thiazol-2-yl]-3-oxopropyl}-L-alaninamide | Formula: | C64 H93 N23 O25 S3 | Definition date: | 2017-08-30 | Last modified: | 2017-12-15 |
|
| PRD_001139 | Name: | (3S,8aR)-2-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]octahydropyrrolo[1,2-a]pyrazine-3-carboxamide | Formula: | C30 H45 N5 O3 | Definition date: | 2013-08-07 | Last modified: | 2017-09-14 |
|
| PRD_002274 | Name: | N-[(6aR,12R,15aR,17R,21R,23aR)-17,21-dimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-Nalpha-[(2E)-pent-2-enoyl]-L-phenylalaninamide | Formula: | C37 H50 N6 O8 | Definition date: | 2017-06-21 | Last modified: | 2017-06-21 |
|
| PRD_001077 | Name: | Cul1WHB-Dcn1P-stapled acetylated | Formula: | C71 H133 N17 O16 Se | Definition date: | 2012-12-12 | Last modified: | 2017-05-04 |
|
| PRD_001132 | Name: | CYCLOSPORIN D | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL) | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
| PRD_002251 | Name: | 3-[(3-hydroxyphenyl)methyl]-10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | Formula: | C34 H50 N4 O8 | Definition date: | 2017-01-25 | Last modified: | 2017-05-04 |
|
| PRD_002240 | Name: | 18-methoxy-2,11,17-trimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | Formula: | C30 H44 N4 O6 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|
| PRD_002241 | Name: | 3-[(3-hydroxyphenyl)methyl]-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | Formula: | C30 H42 N4 O6 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|
| PRD_002245 | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-17-methyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | Formula: | C35 H46 N4 O7 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|
| PRD_002246 | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-2,17-dimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | Formula: | C36 H48 N4 O7 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|
| PRD_002182 | Name: | [amino({3-[(3R,6R,9S,12R,15S,21R,24R,27S,30R,33S,36R,39S)-39-amino-36-(4-ammoniobutyl)-12,33-bis(2-carboxyethyl)-30-(4-hydroxybenzyl)-6-[(1S)-1-hydroxyethyl]-3,21-bis(hydroxymethyl)-27-methyl-9,24-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32,35,38-tridecaoxo-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecaazacyclodotetracontan-15-yl]propyl}amino)methylidene]ammonium | Formula: | C63 H106 N18 O21 | Definition date: | 2015-10-28 | Last modified: | 2015-10-28 |
|
| PRD_001256 | Name: | bifunctional peptide | Formula: | C39 H43 N5 O5 | Definition date: | 2015-01-14 | Last modified: | 2015-01-14 |
|
| PRD_001222 | Name: | bicyclic peptide UK601 (bicyclic 1) | Formula: | C59 H101 N24 O17 S4 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
| PRD_001223 | Name: | bicyclic peptide UK602 (bicyclic 1) | Formula: | C56 H96 N23 O16 S4 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
| PRD_001224 | Name: | bicyclic peptide UK603 (bicyclic 1) | Formula: | C59 H101 N24 O17 S4 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
| PRD_001225 | Name: | bicyclic peptide UK604 (bicyclic 2) | Formula: | C56 H96 N23 O16 S4 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|